Polina Trushina

11 years old, the Moscow Region
Diagnosis: Juvenile rheumatoid arthritis. Rheumatoid uveitis (severe course, secondary glaucoma has developed).
Thanks to Vladimir Chubar (a private donor) and the “Teva” company, which organized charity action “Right on target”, 4 doses of Golimumab 50 mg were purchased for a total amount of 158,600 rubles.

Story

Polina was born on March 5, 2002. She was 3, when her parents noticed some changes in her eyes. Having undergone all the necessary medical tests and examinations, she was diagnosed with juvenile rheumatoid arthritis and rheumatoid uveitis. Rheumatoid uveitis is an inflammation of the choroid. The disease is a manifestation of juvenile rheumatoid arthritis and is a common cause of low vision and blindness.

The girl has a severe course of rheumatoid uveitis which does not respond to treatment with modern drugs. The prognosis of the disease is unfavorable. Secondary glaucoma has developed.  

Golimumab drug (its effectiveness against uveitis was confirmed by foreign research numerous number of times) was recently registered in Russia, and there is not yet any data accumulated on the use of the medication in children. But for Polina it is a last-hope drug. If it doesn’t stop the disease from progressing, this will lead to a complete loss of vision.

Polina is being treated at the Department of Clinical Immunology of the RCCH. Due to the temporary lack of the drug in the hospital pharmacy, it is necessary to purchase 4 doses of Golimumab ASAP (the cost is 158,000 rubles). Otherwise loss of vision will take place.